Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 Nov 6;115(9):858–860.

Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.

J H Joncas, E Rioux, J P Wastiaux, M Leyritz, L Robillard, J Menezes
PMCID: PMC1879112  PMID: 186168

Abstract

Two nasopharyngeal carcinomas of the lymphoepithelioma type and two Burkitt's lymphomas with the characteristic histopathologic features developed in three siblings and one first-degree cousin in a large French-Canadian family. Epstein-Barr virus antibody titres in the two lymphoepithelioma cases but not in the Burkitt's lymphoma cases were, as expected, greatly elevated. HLA typing of the family members failed to disclose HLA antigens A2 and B Sin-2, which have been associated with lymphoepithelioma in Asia. The occurrence, however, of a plasmacytoma in one other first-degree cousin and low serum IgA values in several siblings and cousins suggests the possibility of a genetically determined predisposing B-cell dysfunction in the development of these tumours.

Full text

PDF
858

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betuel H., Camoun M., Colombani J., Day N. E., Ellouz R., de-Thé G. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Cancer. 1975 Aug 15;16(2):249–254. doi: 10.1002/ijc.2910160207. [DOI] [PubMed] [Google Scholar]
  2. Henie G., Henle W., Horwitz C. A. Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J Infect Dis. 1974 Sep;130(3):231–239. doi: 10.1093/infdis/130.3.231. [DOI] [PubMed] [Google Scholar]
  3. Purtilo D. T., Cassel C. K., Yang J. P., Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1975 Apr 26;1(7913):935–940. doi: 10.1016/s0140-6736(75)92004-8. [DOI] [PubMed] [Google Scholar]
  4. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  5. Simons M. J., Day N. E., Wee G. B., Shanmugaratnam K., Ho H. C., Wong S. H., Ti T. K., Yong N. K., Darmalingam S., De-Thé G. Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res. 1974 May;34(5):1192–1195. [PubMed] [Google Scholar]
  6. Simons M. J., Wee G. B., Chan S. H., Shanmugaratnam K. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet. 1975 Jan 18;1(7899):142–143. doi: 10.1016/s0140-6736(75)91433-6. [DOI] [PubMed] [Google Scholar]
  7. Simons M. J., Wee G. B., Day N. E., Morris P. J., Shanmugaratnam K., De-Thé G. B. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer. 1974 Jan 15;13(1):122–134. doi: 10.1002/ijc.2910130114. [DOI] [PubMed] [Google Scholar]
  8. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES